HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea I McClatchey Selected Research

Neurofibromin 2 (Merlin)

1/2018Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis.
1/2018Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.
10/2015NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
5/2014Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.
12/2012Merlin/ERM proteins establish cortical asymmetry and centrosome position.
11/2010The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.
8/2010Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.
6/2009Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma.
8/2008Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture.
6/2007Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea I McClatchey Research Topics

Disease

22Neoplasms (Cancer)
01/2018 - 10/2002
7Carcinogenesis
12/2012 - 03/2003
5Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018 - 06/2007
2Malignant Mesothelioma
05/2014 - 09/2005
2Neurofibromatoses (Neurofibromatosis)
05/2010 - 01/2007
2Neoplasm Metastasis (Metastasis)
02/2004 - 05/2003
1Hepatomegaly
01/2018
1Schwannomatosis
03/2014
1Genomic Instability
12/2012
1Neurofibromatosis 1 (Neurofibromatosis Type I)
07/2012
1Perinatal Death
07/2011
1Neurilemmoma (Schwannoma)
05/2010
1Renal Cell Carcinoma (Grawitz Tumor)
06/2009
1Acoustic Neuroma (Acoustic Neurinoma)
08/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2008
1Leukemia
05/2008
1Lymphoid Leukemia
05/2008
1Ovarian Neoplasms (Ovarian Cancer)
03/2003
1Osteosarcoma (Osteogenic Sarcoma)
03/2003

Drug/Important Bio-Agent (IBA)

13Neurofibromin 2 (Merlin)IBA
01/2018 - 05/2003
8Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2003
5ezrinIBA
01/2018 - 02/2004
3ErbB Receptors (EGF Receptor)IBA
10/2015 - 06/2009
2AsbestosIBA
05/2014 - 09/2005
2moesinIBA
12/2012 - 11/2010
2radixinIBA
12/2012 - 11/2010
2Phosphotransferases (Kinase)IBA
05/2012 - 09/2005
2Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2009 - 08/2008
1Growth Factor ReceptorsIBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
03/2015
1Lipid NanoparticlesIBA
03/2015
1PND 1186IBA
05/2014
1Focal Adhesion Protein-Tyrosine KinasesIBA
05/2014
1Aldehyde DehydrogenaseIBA
05/2014
1tyrosine receptor (receptor, tyrosine)IBA
05/2012
1Long-Acting Thyroid Stimulator (LATS)IBA
08/2010
1Semaphorins (Semaphorin)IBA
05/2010
1Bevacizumab (Avastin)FDA Link
05/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010
1villinIBA
06/2009
1CeramidesIBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
05/2008
1NucleotidesIBA
05/2008
1DNA (Deoxyribonucleic Acid)IBA
09/2005
1Cadherins (E-Cadherin)IBA
05/2003
1GTP Phosphohydrolases (GTPases)IBA
03/2003
1AgarIBA
03/2003
1Biomarkers (Surrogate Marker)IBA
10/2002

Therapy/Procedure

8Therapeutics
03/2014 - 10/2002
1Drug Therapy (Chemotherapy)
05/2014
1Aftercare (After-Treatment)
05/2010
1Hearing Aids (Hearing Aid)
08/2008